 2. Participants with a histologic diagnosis of ovarian, primary peritoneal, or fallopian tube carcinoma, Stage Ib- IV, with either optimal 1 cm residual disease or suboptimal residual disease 1 cm maximal diameter any remaining lesion following initial surgery. 